URIDINE TRIACETATE
| Brand name | VISTOGARD |
|---|---|
| Active ingredient | URIDINE TRIACETATE |
| Strength | 10GM/PACKET |
| Dosage form | GRANULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | December 2015 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7776838 | August 2027 | use U-1791 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.